The Scientist

» PCR, immunology and developmental biology

Most Recent

image: Suited to a T

Suited to a T

By | May 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

1 Comment

image: Viruses on the Brain

Viruses on the Brain

By | May 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

image: Why So Soon?

Why So Soon?

By | May 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

4 Comments

image: Branching Out

Branching Out

By | April 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

image: Mimicking Mussels

Mimicking Mussels

By | April 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

1 Comment

image: Pluripotent Until Needed

Pluripotent Until Needed

By | April 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

image: Smurf-y Old Age

Smurf-y Old Age

By | April 1, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

image: Science Loses Two More

Science Loses Two More

By | March 6, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

image: All In Proportion

All In Proportion

By | March 2, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

image: Antibody-Dependent Enhanced (ADE) Immunity

Antibody-Dependent Enhanced (ADE) Immunity

By | March 2, 2013

Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech